Skip to Content

← See all Senokot brands

Senokot by Avrio Health L.P.

Dosage form: tablet
Ingredients: SENNOSIDES 8.6mg
Labeler: Avrio Health L.P.
NDC Code: 67618-300

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Senokot
standardized senna concentrate

Drug Facts
Active ingredient (in each tablet)

Sennosides 8.6 mg

Laxative

Uses

  • relieves occasional constipation (irregularity)
  • generally produces a bowel movement in 6-12 hours

Warnings

Do not use

  • laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • take preferably at bedtime or as directed by a doctor
agestarting dosagemaximum dosage
adults and children
12 years of age and over
2 tablets once a day4 tablets twice a day
children 6 to under 12 years1 tablet once a day2 tablets twice a day
children 2 to under 6 years1/2 tablet once a day1 tablet twice a day
children under 2 yearsask a doctorask a doctor

Other Information

  • each tablet contains: calcium 10 mg
  • store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)

Inactive ingredients

dicalcium phosphate, magnesium stearate, microcrystalline cellulose, pregelatinized starch

©2018



Avrio Health L.P.
Stamford, CT 06901-3431

305018-0A

100 Tablets

SENOKOT 
standardized senna concentrate tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:67618-300
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (SENNOSIDES) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS 
MAGNESIUM STEARATE 
CELLULOSE, MICROCRYSTALLINE 
STARCH, CORN 
Product Characteristics
ColorBROWNScoreno score
ShapeROUNDSize9mm
FlavorImprint CodeS
Contains    
Packaging
#Item CodePackage Description
1NDC:67618-300-401 BLISTER PACK in 1 CARTON
14 TABLET in 1 BLISTER PACK
2NDC:67618-300-243 BLISTER PACK in 1 CARTON
224 TABLET in 1 BLISTER PACK
3NDC:67618-300-202 BLISTER PACK in 1 CARTON
310 TABLET in 1 BLISTER PACK
4NDC:67618-300-501 BOTTLE, PLASTIC in 1 CARTON
450 TABLET in 1 BOTTLE, PLASTIC
5NDC:67618-300-101 BOTTLE, PLASTIC in 1 CARTON
5100 TABLET in 1 BOTTLE, PLASTIC
6NDC:67618-300-044 TABLET in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33406/01/1956
Labeler - Avrio Health L.P. (141916531)
Registrant - Purdue Pharma LP (932323652)
Establishment
NameAddressID/FEIOperations
Purdue Pharma250955291MANUFACTURE(67618-300)

 
Avrio Health L.P.

Medically reviewed on Oct 12, 2018

See Also

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide